Comprehensive Drug Development
Analytical Drug Development - Drug Formulation - GMP Manufacturing
Velesco applies nimblocity to your early phase drug development projects, with our proven formulation of expertise, flexibility, dedication and velocity to clinic.
Expertise and Experience
Velesco is a contract research organization (CRO) providing Chemistry, Manufacturing, and Controls (CMC) services to the pharmaceutical industry. Velesco is founded and staffed by pharmaceutical scientists from Pfizer's former Michigan Research & Development campus. Our team of pharmaceutical company veterans has experience with more than 300 drug development programs.
Our nimble drug development processes and focused pharmaceutical expertise enables us to overcome even the most challenging pharmaceutical development obstacles. Our team is responsive, accommodating and eager to help you reach the full potential of your drug compound, quickly and efficiently.
We treat your pharmaceutical-development project like it's our own and share everything from insightful observations to solutions for problematic analytical method validation to assistance with the FDA registration process. All of our pharmaceutical consulting services are royalty-free.
Velocity to Clinic
We're committed to getting your compound to the clinic on time. Our size, capacity, and expertise allow us to accommodate changes swiftly while maintaining control and quality.
As experts in pharmaceutical analytical chemistry, drug formulation development, and cGMP clinical supply manufacturing, Velesco pharmaceutical scientists have a proven track record of moving compounds through the critical drug development process with nimblocity and unrivaled success.
News and Events
CEO Dave Barnes has been published in a new Pharmoutsourcing article on Clinical Trial Materials and Manufacturing!
2 new job postings! Careers
Velesco will be at AAPS PharmSci360 in November in Washington, DC!
Come visit us at booth #2415!
Velesco has been awarded a subcontract for analytical method development, manufacturing clinical supplies, and testing the stability of an investigational drug for the treatment of Beta-Thalassemia through the NCATS! Read the press release here.
We celebrated our 10th anniversary in 2017!
Velesco's work published in
a Drug Development & Delivery article!
Read it here.